Streetbeat News

Products Services

PINS

VERB

Verb Technology Company, Inc. (VERB) has launched a new technology integration with Pinterest to enhance its MARKET.live social shopping platform. This partnership aims to leverage Pinterest's large user base to expand MARKET.live's reach for consumer brand clients.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:02 pm

REPL

Replimune has completed a pre-BLA meeting with the FDA for its product RP1 and confirmed that the BLA submission is on track for the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:01 pm

JAZZ

Jazz Pharmaceuticals will present five abstracts at the ESMO Congress 2024, showcasing trials of zanidatamab and Zepzelca. The presentations will include new data on zanidatamab for HER2-positive cancers, highlighting its potential in treating metastatic gastroesophageal adenocarcinoma and colorectal cancer.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 12:00 pm

STLA

The U.S. National Highway Traffic Safety Administration (NHTSA) is investigating 781,459 Stellantis vehicles, including Jeep Wrangler and Gladiator models, for potential fire hazards. The probe follows a recall of over 1.2 million Ram 1500 vehicles due to software issues. The investigation focuses on fires occurring when the ignition is off, with reports indicating the power steering pump electrical connector as a potential source.

Portfolio Pulse from Benzinga Neuro

September 09, 2024 | 11:58 am

TNXP

Tonix Pharmaceuticals shares rose following the announcement of data on their potential mpox vaccine, TNX-801, presented at an immunology symposium.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:56 am

PYPL

SHOP

PayPal has expanded its partnership with Shopify, integrating PayPal Complete Payments into Shopify Payments for US merchants. This integration aims to streamline payment processes and enhance operational efficiency for merchants.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:41 am

MBLY

Mobileye has decided to end its internal lidar development, which is not expected to materially impact its 2024 results. This move will avoid future lidar development spending, with 2024 operating expenses for the lidar R&D unit estimated at $60 million.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:40 am

MRNA

Moderna's manufacturing facility in Laval, Quebec, has received a Drug Establishment License from Health Canada, allowing it to produce mRNA vaccines domestically. This milestone positions Moderna to ensure a reliable supply of vaccines in Canada, with production expected to start in 2025.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:39 am

CCCC

C4 Therapeutics shares are trading lower following the release of clinical data from its Phase 1 trial of CFT1946 for BRAF V600 mutant solid tumors, shared at the ESMO Congress 2024.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:39 am

INTC

MBLY

Mobileye has decided to cease the internal development of next-generation FMCW Lidars, winding down its Lidar R&D unit by the end of 2024. This decision affects about 100 employees and is influenced by progress in computer vision perception, improved imaging radar performance, and cost reductions in third-party lidar units.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 11:38 am